Work

Phase I trial of low-dose continuous topotecan infusion in patients with cancer: an active and well-tolerated regimen.

Year: 1994

Type: article

Study design: Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.1994.12.3.553

Authors: H Hochster, L Liebes, J Speyer, J Sorich, B Taubes, R Oratz, J Wernz, A Chachoua, B Raphael, R Z Vinci

Institutions: NYU Langone Health, New York University

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute, National Center for Research Resources

Awards: TOPOISOMERASE-1 INHIBITORS: NOVEL THERAPY OF UPPER GI CA, G410569412, G5953508653, G7693519967, Cancer Center Support Grant

OpenAlex ID: W2108018389

FWCI: 6.716

Cites: 7

Cited by: 162

Related to: 10